INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.740
+0.090 (5.45%)
At close: Nov 28, 2025, 4:00 PM EST
1.711
-0.029 (-1.69%)
After-hours: Nov 28, 2025, 4:32 PM EST
Revenue by Product
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.